Leukemia characterised by rearrangement of the mixed lineage leukemia (MLL) gene is a highly aggressive cancer that occurs in over 70% of infant acute lymphoblastic leukemia (ALL) and 35-50% of infant acute myeloid leukemia (AML) [1, 2]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.